Hereditary Risk Factors for Thyroid Cancer

Not Applicable

Recruiting

• Conditions: Thyroid Cancer
• Interventions: Genetic: •Referral to Genetic Counselor, if indicated

• Registration Number: NCT02747888
• Lead Sponsor: Dana-Farber Cancer Institute

Brief Summary

Thyroid cancers can occur sporadically, but can also be found as tumors that cluster in families with other cancers or genetic syndromes. Researchers are studying thyroid cancer in children and families, with a particular interest in understanding genes and other factors that may put individuals at risk for developing thyroid cancer and thyroid nodules.

* In this study, family and medical history information is collected alongside a blood or saliva sample for genetic studies.

* Individuals with a past or present childhood thyroid cancer/nodule or a thyroid cancer suspected to be inherited in their family are invited to participate.

Detailed Description

The purpose of this research study is to learn more about risk factors for inherited thyroid cancer.

The investigators would like to use the participant DNA to look for alterations in genes. The investigator will perform DNA sequencing and other genetic studies to identify errors in the genes that may contribute to the formation of thyroid nodules and cancer.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2016-03-01
• Study First Submitted: 2016-03-31
• Study First Submitted QC: 2016-04-19
• Study First Posted: 2016-04-22
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-01
• Last Update Posted: 2024-04-03
• Primary Completion: 2029-03-01
• Study Completion: 2029-03-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• Individual pediatric patient with current or previous known or suspected thyroid cancer or nodule(s).

• Individual adult patient with current or previous known or suspected thyroid cancer or nodule(s) if they come from a family with a high suspicion of hereditary cancer (as below).

• Individuals from families with a high suspicion of hereditary thyroid cancer:

  • Families with a current or previous diagnosis of a thyroid cancer/nodule occurring in childhood (<18 years old).

  • Families with a high suspicion of hereditary thyroid cancer/nodules other than above to include:

    • Families with thyroid cancer in multiple individuals
    • Families with thyroid cancer and a known genetic syndrome
    • Families with thyroid cancer and a suspected genetic syndrome (e.g. multiple childhood cancers in the family, multiple primary cancers, multiple endocrinopathies, etc.)

Read More

Exclusion Criteria

• Individuals who are unable to give informed consent.
• Individuals who are unable to complete study materials.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Higher Suspected Familial Predisposition	•Referral to Genetic Counselor, if indicated	Higher Suspected Familial Predisposition Screening and Enrollment: Consent, Family HX, Medical HX, Blood/Saliva which will categorize by suspected hereditary predisposition: Based on family and medical history. - Specimen Testing and Analysis •Referral to Genetic Counselor, if indicated

Primary Outcome Measures

Name	Time	Method
Number of participants who have childhood or suspected familial thyroid nodules/cancer	2 years
Number of germline mutations identified associated with thyroid cancer predisposition	2 years
Prevalence of suspected familial thyroid cancer among those with childhood thyroid nodules/cancer	2 years

Trial Locations

Locations (1)

Dana Farber Cancer Institute; 🇺🇸 Boston, Massachusetts, United States